Medication Guide

In the pursuit of health and recovery, rational use of drugs is a crucial part. Patients should be fully aware of the information about the drug, including but not limited to efficacy, dosage, and contraindications, before using any drug. Be sure to follow the doctor's guidance and do not increase or decrease the dose or change the drug at will, so as not to affect the efficacy or cause adverse reactions; Be aware of drug-drug interactions and avoid self-medication.

Gefitinib(Iressa)

It is indicated for the first-line treatment of patients with metastatic non-small cell lung cancer whose tumors have been confirmed to harbor EGFR exon 19 deletions or exon 21 (L8···【more】
Article source：Captain MedicineRelease date：2026-01-05Recommended：43
Idelalisib(Zydelig)

A kinase inhibitor used in combination with rituximab for the treatment of relapsed chronic lymphocytic leukemia.【more】
Article source：Captain MedicineRelease date：2026-01-05Recommended：86
Infigratinib(Truseltiq)

It is indicated for the treatment of adult patients with previously treated, unresectable locally advanced or metastatic cholangiocarcinoma with FGFR2 gene abnormalities.【more】
Article source：Captain MedicineRelease date：2026-01-05Recommended：68
Lazertinib(Leclaza)

It is indicated for the first-line treatment of adult patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) harboring epidermal growth factor receptor (EG···【more】
Article source：Captain MedicineRelease date：2026-01-05Recommended：55
Lenacapavir(Sunlenca)

In combination with other antiretroviral drugs, it is indicated for the treatment of heavily treated adult HIV-1-infected patients with multidrug resistance whose current antiretro···【more】
Article source：Captain MedicineRelease date：2026-01-05Recommended：44
Lenalidomide(Revlimid)

It is used for the treatment of various hematological diseases such as multiple myeloma, myelodysplastic syndromes, mantle cell lymphoma, follicular lymphoma, and marginal zone lym···【more】
Article source：Captain MedicineRelease date：2026-01-05Recommended：77
Obeticholic(Ocaliva)

It is indicated for the treatment of adult patients with primary biliary cholangitis who have an inadequate response to or are intolerant of ursodeoxycholic acid (UDCA), and who ha···【more】
Article source：Captain MedicineRelease date：2026-01-05Recommended：50
Lusutrombopag(Mulpleta)

It is indicated for the treatment of thrombocytopenia in adult patients with chronic liver disease who develop the condition prior to undergoing surgery.【more】
Article source：Captain MedicineRelease date：2026-01-05Recommended：69
Macitentan(Opsumit)

It is indicated for the treatment of adult patients with pulmonary arterial hypertension (PAH, WHO Group 1) to reduce the risk of disease progression and hospitalization.【more】
Article source：Captain MedicineRelease date：2026-01-05Recommended：74
Mavacamten(Camzyos)

It is indicated for the treatment of adult patients with symptomatic obstructive hypertrophic cardiomyopathy (HCM) classified as New York Heart Association (NYHA) Class Ⅱ-Ⅲ, to imp···【more】
Article source：Captain MedicineRelease date：2026-01-05Recommended：82
Neratinib(Nerlynx)

It is indicated for the treatment of early-stage and advanced-stage HER2-positive breast cancer, and can be used as a monotherapy for adjuvant treatment or in combination with cape···【more】
Article source：Captain MedicineRelease date：2026-01-05Recommended：65
Nintedanib(OFEV)

It is indicated for the treatment of idiopathic pulmonary fibrosis (IPF), chronic fibrosing interstitial lung disease (ILD), and systemic sclerosis-associated interstitial lung dis···【more】
Article source：Captain MedicineRelease date：2026-01-05Recommended：94

home page previous 49 49/102 next last page

News

The U.S. FDA approved the combination of Pembrolizumab and Enfortumab vedotin-ejfv for the treatment
On November 21, 2025, the U.S. Food and Drug Administration (FDA) approved the regimen of pembrolizu···【more】

Recommended：[list:visits]2025-17-12
Lucius Pharmaceuticals Laos launched lorlatinib, a third-generation targeted drug for lung cancer
Lung cancer is the most rapidly increasing malignant tumor with the fastest increasing morbidity and···【more】

Recommended：[list:visits]2024-09-07
Lucius Pharmaceuticals Version of Vibegron Now Available
Lucius Pharmaceuticals Version of Vibegron Now Available1.Basic Drug InformationVibegron (generic na···【more】

Recommended：[list:visits]2026-06-08
Lao Pharmacies and Manufacturer Direct Shipping: Legal Pathways and Pitfall Guide for Overseas Medi
In recent years, leveraging the World Trade Organization (WTO) patent waiver for least-developed cou···【more】

Recommended：[list:visits]2026-05-08
How Can Chinese Patients Access Generic Drugs from Laos?
How Can Chinese Patients Access Generic Drugs from Laos?In recent years, generic drugs from Laos hav···【more】

Recommended：[list:visits]2026-04-08
Lucius Pharmaceuticals version of Ibrutinib is now available
Lucius Pharmaceuticals version of Ibrutinib is now availableIn a randomized controlled trial of 269 ···【more】

Recommended：[list:visits]2026-03-08
Laos Lucius, ASEAN Pharmaceuticals (TLPH), and Alliance Pharmaceuticals: Which generic drug manufac
Leveraging the WTO patent waiver for least-developed countries (extended to 2033), Laos has seen rap···【more】

Recommended：[list:visits]2026-31-07
Alectinib Has Been Launched in Laos
Alectinib Has Been Launched in LaosAlectinib is an oral targeted therapeutic drug belonging to the c···【more】

Recommended：[list:visits]2026-30-07

Lucius Pharmaceuticals

Lucius Pharmaceuticals (Lao) LTD. (Lucius Pharmaceuticals), with its manufacturing campus in Laos located in the capital city of Vientiane in 2020, officially begins its great journey to make effective and affordable medicines available to people in need around the world...More